These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36669426)

  • 1. Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity.
    Laskar SG; Chaukar D; Deshpande M; Chatterjee A; Sinha S; Chakraborty S; Agarwal JP; Gupta T; Budrukkar A; Murthy V; Pai P; Chaturvedi P; Pantvaidya G; Deshmukh A; Nair D; Nair S; Prabhash K; Swain M; Kumar A; Noronha V; Patil V; Joshi A; DCruz A
    Eur J Cancer; 2023 Mar; 181():179-187. PubMed ID: 36669426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response to letter entitled: Re: Oral cavity adjuvant therapy (OCAT) - a phase III, randomised controlled trial of surgery followed by conventional radiotherapy (5 fr/wk) versus concurrent CT-RT versus accelerated radiotherapy (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity.
    Ghosh-Laskar S; Chatterjee A; Sinha S
    Eur J Cancer; 2023 Aug; 189():112922. PubMed ID: 37321931
    [No Abstract]   [Full Text] [Related]  

  • 3. Letter Re: Oral cavity adjuvant therapy-a phase III, randomised controlled trial of surgery followed by conventional radiotherapy (5 fr/wk) versus concurrent CT-RT versus accelerated radiotherapy (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity.
    Kahvecioglu A; Sari SY; Yazici G
    Eur J Cancer; 2023 Aug; 189():112918. PubMed ID: 37321930
    [No Abstract]   [Full Text] [Related]  

  • 4. Long-term outcomes in oral cavity squamous cell carcinoma with adjuvant and salvage radiotherapy after surgery.
    Katsoulakis E; Leeman JE; Lok BH; Shi W; Zhang Z; Tsai JC; McBride SM; Sherman EJ; Cohen M; Wong R; Ganly I; Lee NY; Riaz N
    Laryngoscope; 2018 Nov; 128(11):2539-2545. PubMed ID: 29637571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of treatment and high-risk features in resectable locally advanced Head and Neck squamous cell carcinoma with special reference to extracapsular extension of nodal disease.
    Krstevska V
    J BUON; 2015; 20(4):943-53. PubMed ID: 26416042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity - The ARTSCAN 2 study.
    Wennerberg J; Gebre-Medhin M; Nilsson P; Brun E; Kjellén E; Carlwig K; Reizenstein J; Kristiansson S; Söderkvist K; Wahlgren M; Zackrisson B;
    Radiother Oncol; 2022 Jan; 166():26-32. PubMed ID: 34793864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase 2 Trial of Chemoradiation Therapy Using Weekly Docetaxel for High-Risk Postoperative Oral Squamous Cell Carcinoma Patients.
    Li R; Jiang W; Dou S; Zhong L; Sun J; Zhang C; Zhu G
    Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):462-468. PubMed ID: 32126267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of High-Risk Subgroups of Patients With Oral Cavity Cancer in Need of Postoperative Adjuvant Radiotherapy or Chemo-Radiotherapy.
    Chen WC; Lai CH; Fang CC; Yang YH; Chen PC; Lee CP; Chen MF
    Medicine (Baltimore); 2016 May; 95(22):e3770. PubMed ID: 27258508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II/III Randomized Controlled Trial of Concomitant Hyperfractionated Radiotherapy plus Cetuximab (Anti-EGFR Antibody) or Chemotherapy in Locally Advanced Head and Neck Cancer.
    Al-Saleh K; El-Sherify M; Safwat R; Elbasmy A; Shete J; Hussein A; Nazeeh M; Bedair A
    Gulf J Oncolog; 2019 May; 1(30):6-12. PubMed ID: 31242976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx.
    Fallai C; Bolner A; Signor M; Gava A; Franchin G; Ponticelli P; Taino R; Rossi F; Ardizzoia A; Oggionni M; Crispino S; Olmi P
    Tumori; 2006; 92(1):41-54. PubMed ID: 16683383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant therapy improves survival in pT4aN0 oral cavity squamous cell carcinoma with bone invasion.
    Stanford-Moore GB; Sola AM; Chan J; El-Sayed I; George J; Ha P; Ryan WR; Heaton CM
    Am J Otolaryngol; 2022; 43(2):103303. PubMed ID: 34894450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial.
    Tao Y; Biau J; Sun XS; Sire C; Martin L; Alfonsi M; Prevost JB; Modesto A; Lafond C; Tourani JM; Miroir J; Kaminsky MC; Coutte A; Liem X; Chautard E; Vauleon E; Drouet F; Ruffier A; Ramee JF; Waksi G; Péchery A; Wanneveich M; Guigay J; Aupérin A; Bourhis J
    Ann Oncol; 2023 Jan; 34(1):101-110. PubMed ID: 36522816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Traditional risk factors and nodal yield-still relevant with high-quality risk-adapted adjuvant treatment for locally advanced head and neck cancer?
    Butt Y; Tennstedt P; Busch CJ; Hanken H; Krüll A; Petersen C; Tribius S
    Strahlenther Onkol; 2023 Mar; 199(3):284-292. PubMed ID: 36350358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative radiotherapy with docetaxel versus cisplatin for high-risk oral squamous cell carcinoma: a randomized phase II trial with exploratory analysis of ITGB1 as a potential predictive biomarker.
    Jiang W; Chen L; Li R; Li J; Dou S; Ye L; He Y; Tian Z; Yao Y; Zhu G
    BMC Med; 2024 Jul; 22(1):314. PubMed ID: 39075531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preservation of swallowing in resected oral cavity squamous cell carcinoma: examining radiation volume effects (PRESERVE): study protocol for a randomized phase II trial.
    Lang P; Contreras J; Kalman N; Paterson C; Bahig H; Billfalk-Kelly A; Brennan S; Rock K; Read N; Venkatesan V; Sathya J; Mendez LC; MacNeil SD; Nichols AC; Fung K; Mendez A; Winquist E; Kuruvilla S; Stewart P; Warner A; Mitchell S; Theurer JA; Palma DA
    Radiat Oncol; 2020 Aug; 15(1):196. PubMed ID: 32795322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of microscopic versus macroscopic extranodal extension in oral cavity squamous cell carcinoma: National cancer database analysis and review of the literature.
    Quinton BA; Cabrera CI; Tamaki A; Li S; Fowler N; Rezaee R; Lavertu P; Teknos T; Pan Q; Thuener J
    Am J Otolaryngol; 2022; 43(4):103511. PubMed ID: 35609426
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of purely accelerated six fractions per week radiotherapy in postoperative oral cavity squamous cell carcinoma.
    Rath S; Khurana R; Sapru S; Rastogi M; Gandhi AK; Hadi R; Sahni K; Mishra SP; Srivastava AK; Syedkather F
    Asia Pac J Clin Oncol; 2020 Feb; 16(1):14-22. PubMed ID: 31793206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.